About:
Eligibility
-
Weight of at least 40 kg
-
On a stable prescribed standard of care (SoC) treatment regimen according to local guidelines and the specific requirements for each disease
-
Systolic blood pressure ≤160 mmHg and diastolic blood pressure ≤90 mmHg at Screening. For participants aged ≥10 to <18 years, the average of 3 separate systolic and/or diastolic blood pressures <95th percentile for age, gender, and height
**There are other criteria that potential participants must meet in order to qualify for the study**
(eligibility varies by cohort)
A Phase 2 Study to Evaluate the Safety and Efficacy of Atacicept in Multiple Autoimmune Glomerular Diseases (PIONEER): IgA, pMN, MCD/FSGS.
Open label study (No placebo).
If you’re interested in participating in one of our Research Studies:
Call
303-232-3366
ext 2150, 2170, 2190 or 7330